The authors compared eGFR based on serum creatinine and cystatin C levels in 53 patients with testicular cancer and showed that creatinine-based eGFR was significantly lower than cystatin C-based eGFR (p<0.05). This evidence concerns the gene CST3 and testicular cancer.